Poolbeg Pharma is stepping up partnering discussions with multiple pharma groups
2 Articles
2 Articles
Poolbeg Pharma is stepping up partnering discussions with multiple pharma groups
Poolbeg Pharma PLC (AIM: POLB) is stepping up partnering discussions with multiple pharma groups as it approaches a series of near-term clinical catalysts that could unlock a deal. Lead assetRead More...
Poolbeg Pharma plc - Results for the year ended 31 December 2025
28 April 2026 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces its audited results for the year ended 31 December 2025. Read more… The post Poolbeg Pharma plc – Results for the year ended 31 December 2025 appeared first on Optimum Strategic Communications.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
